Biocompatibles to evaluate Bead Block for uterine fibroids
This article was originally published in Clinica
Executive Summary
UK company Biocompatibles International has told Clinica it is soon to begin clinical evaluation of its Bead Block embolisation therapy for treating uterine fibroids. The Farnham, Surrey-based company said a non-US clinical trials programme is scheduled to commence later this year.
You may also be interested in...
HHS Policy Move Means FDA Must Publish More Documentation To Support Rulemaking Decisions
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's Strengthens Russian OTC Portfolio Through Glenmark Deal
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Moderna Files COVID-19 Vaccine After Second Impressive Read-Out
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: